{"id":210417,"date":"2018-04-26T15:00:12","date_gmt":"2018-04-26T15:00:12","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=210417"},"modified":"2018-04-26T15:00:12","modified_gmt":"2018-04-26T15:00:12","slug":"creative-biolabs-announced-membrane-protein-antibodies-service","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/creative-biolabs-announced-membrane-protein-antibodies-service_210417.html","title":{"rendered":"Creative Biolabs Announced Membrane Protein Antibodies Service"},"content":{"rendered":"
As a pioneer and the undisrupted global leader in antibody engineering and discovery, Creative Biolabs recently introduced the professional membrane Protein Antibodies service with diverse technologies to better serve the global clients.<\/div>\n

Consisting of 20~30% of total encoding genes in the genome, membrane proteins play a critical role in multiple biological processes, including ligand-receptor binding, signal transduction, molecule transportation, intercellular recognition, and cell adhesion. Currently, membrane antibody <\/span><\/a>becomes a promising choice in the field of various drug development and other applications.<\/p>\n

“Generally, the expression and presentation of the membrane protein of interest as immunogen is the prerequisite to obtain highly functional anti-membrane protein antibodies. Our novel Magic™ platform enables high-efficient expression of membrane proteins, following antibody development routes based on our multiple impeccable technologies. ” a scientist from Creative Biolabs said that.<\/p>\n

“In addition, our cell-based membrane protein expression system can yield membrane proteins of interest from a recombinant plasmid in living cell system. This platform is highly flexible for multiple options of host organisms, including E.coli<\/em>, yeast cells, baculovirus-insect cells, mammalian cells, and photosynthetic bacteria ”<\/p>\n

Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs is always dedicated to assisting our clients with the most satisfactory membrane protein antibody related services. In addition, we provide large scale production of recombinant single domain antibodies at the most competitive price.<\/p>\n

About Creative Biolabs<\/p>\n

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies (including phage display, bacterial display and yeast display).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Creative Biolabs
Contact Person:<\/strong> Bella Smith
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 1-631-619-7922
Address:<\/strong>45-1 Ramsey Road
City:<\/strong> Shirley
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.creative-biolabs.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

As a pioneer and the undisrupted global leader in antibody engineering and discovery, Creative Biolabs recently introduced the professional membrane Protein Antibodies service with diverse technologies to better serve the global clients. Consisting of 20~30% of total encoding genes in … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-210417","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/210417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=210417"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/210417\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=210417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=210417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=210417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}